Speed Your Path to Patients with Integrated Solutions for Plasmid DNA Development & Manufacturing
Summary: Plasmid DNA is a critical starting material for advanced therapeutics, such as viral vector-mediated cell and gene therapies. To support your therapeutic programs, Catalent offers extensive expertise in the bioproduction of plasmid DNA, from early stages of development to CGMP manufacturing to satisfy clinical and commercial needs.
Key Learnings:
- Catalent offers extensive expertise in the bioproduction of plasmid DNA, from early stages of development to CGMP manufacturing to satisfy clinical and commercial needs.
- Catalent’s UpTempo℠ plasmid platform process offers a streamlined solution for the transition of programs from pre-clinical to clinical development.
- Catalent offers a wide range of off-the-shelf plasmids that can significantly help reduce development costs, risks, and timelines for cell and gene therapy developers.